A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Cited by (1,008)

Items 1,001–1,008 of 1,008

1. Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore
   Saavedra, Juan M. · 2021 · Physiology
2. Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients
   Latil, Mathilde, Camelo, Serge, Veillet, Stanislas, Lafont, René, Dilda, Pierre J. · 2021 · Drug Discovery Today
3. Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19
   Agarwal, Sangya, June, Carl H. · 2020 · Cancer Discovery
4. Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2
   Kim, Jeonghwan, Mukherjee, Anindit, Nelson, Dylan, Jozic, Antony, Sahay, Gaurav · 2020
5. Anti-inflammatory effects of GLP-1 in patients with COVID-19
   Sazgarnejad, Saharnaz, Yazdanpanah, Niloufar, Rezaei, Nima · 2022 · Expert Review of Anti-infective Therapy
6. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
   Devaux, Christian A., Camoin-Jau, Laurence · 2022 · Frontiers in Microbiology
7. A comprehensive review on modulation of <scp>SIRT1</scp> signaling pathways in the immune system of <scp>COVID</scp> ‐19 patients by phytotherapeutic melatonin and epigallocatechin‐3‐gallate
   Chattree, Vineeta, Singh, Kamana, Singh, Kanishk, Goel, Aayush, Maity, Amritaparna, Lone, Asif · 2022 · Journal of Food Biochemistry
8. Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data
   Wang, Zhihan, Guo, Kai, Gao, Pan, Pu, Qinqin, Wu, Min, Li, Changlong, Hur, Junguk · 2020 · arXiv